Total Payments
$8,367
2024 Payments
$478.48
Companies
34
Transactions
380
Medicare Patients
967
Medicare Billing
$83,609
Payment Breakdown by Category
Food & Beverage$8,323 (99.5%)
Education$43.77 (0.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,323 | 376 | 99.5% |
| Education | $43.77 | 4 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,535 | 61 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $974.19 | 49 | $0 (2020) |
| PFIZER INC. | $961.77 | 46 | $0 (2024) |
| Amgen Inc. | $802.90 | 30 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $509.66 | 18 | $0 (2023) |
| Medtronic USA, Inc. | $432.14 | 21 | $0 (2018) |
| Novo Nordisk Inc | $349.76 | 17 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $347.60 | 23 | $0 (2024) |
| ViiV Healthcare Company | $299.66 | 11 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $283.26 | 13 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $478.48 | 17 | Novo Nordisk Inc ($166.47) |
| 2023 | $187.97 | 11 | PFIZER INC. ($37.71) |
| 2022 | $532.12 | 35 | ABBVIE INC. ($159.09) |
| 2021 | $1,222 | 60 | Amgen Inc. ($197.64) |
| 2020 | $882.77 | 48 | AstraZeneca Pharmaceuticals LP ($234.69) |
| 2019 | $1,183 | 48 | Sunovion Pharmaceuticals Inc. ($297.11) |
| 2018 | $2,468 | 101 | Janssen Pharmaceuticals, Inc ($441.75) |
| 2017 | $1,413 | 60 | PFIZER INC. ($401.99) |
All Payment Transactions
380 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/22/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: Inflammation | ||||||
| 10/22/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: Cardiology | ||||||
| 10/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.08 | General |
| Category: Diabetes | ||||||
| 08/13/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $19.21 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/03/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: Diabetes | ||||||
| 07/10/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/26/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: NEUROLOGY | ||||||
| 05/31/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: Inflammation | ||||||
| 05/21/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $119.70 | General |
| Category: Respiratory | ||||||
| 04/30/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/09/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.23 | General |
| Category: Obesity | ||||||
| 03/28/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: Diabetes | ||||||
| 03/21/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $96.90 | General |
| 02/29/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug), FARXIGA | Food and Beverage | In-kind items and services | $24.38 | General |
| Category: Respiratory | ||||||
| 02/23/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: Diabetes | ||||||
| 01/26/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $19.27 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 01/18/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: Insomnia | ||||||
| 11/07/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: Diabetes | ||||||
| 10/27/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $19.83 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/12/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/28/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: Respiratory | ||||||
| 05/17/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: Diabetes | ||||||
| 04/19/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: INSOMNIA | ||||||
| 04/14/2023 | MEDLINE INDUSTRIES LP | — | Food and Beverage | In-kind items and services | $17.06 | General |
| 04/05/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 173 | 317 | $29,278 | $21,478 |
| 2022 | 8 | 160 | 310 | $24,470 | $15,564 |
| 2021 | 10 | 302 | 485 | $41,270 | $23,225 |
| 2020 | 10 | 332 | 559 | $35,549 | $23,342 |
Total Patients
967
Total Services
1,671
Medicare Billing
$83,609
Procedure Codes
37
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 34 | 157 | $12,335 | $9,033 | 73.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 25 | 28 | $3,760 | $2,745 | 73.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 19 | 27 | $3,636 | $2,280 | 62.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 14 | 17 | $3,217 | $2,223 | 69.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 19 | 19 | $2,185 | $2,141 | 98.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 13 | 15 | $1,800 | $1,202 | 66.8% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 12 | 12 | $975.00 | $709.05 | 72.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 21 | 26 | $650.00 | $637.00 | 98.0% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2023 | 16 | 16 | $720.00 | $507.52 | 70.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 20 | 131 | $10,288 | $6,915 | 67.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 23 | 23 | $2,840 | $2,632 | 92.7% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 14 | 19 | $2,982 | $1,936 | 64.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 15 | 25 | $2,804 | $1,915 | 68.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 21 | 22 | $3,633 | $1,409 | 38.8% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 14 | 26 | $695.50 | $403.01 | 57.9% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2022 | 16 | 17 | $428.40 | $213.04 | 49.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 37 | 47 | $799.00 | $140.31 | 17.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 23 | 132 | $14,287 | $7,252 | 50.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 37 | 37 | $5,160 | $4,549 | 88.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 37 | 42 | $6,110 | $3,227 | 52.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 18 | 25 | $5,168 | $2,598 | 50.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 38 | 44 | $4,924 | $2,571 | 52.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 15 | 21 | $3,242 | $1,696 | 52.3% |
| 90756 | Vaccine for influenza derived from cell cultures for injection into muscle, quadrivalent, antibiotic free, 0.5ml dosage | Office | 2021 | 14 | 14 | $638.00 | $395.84 | 62.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 83 | 130 | $776.00 | $390.00 | 50.3% |
About Dr. William Haney, MD
Dr. William Haney, MD is a Pediatrics healthcare provider based in Louisville, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1538250147.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Haney, MD has received a total of $8,367 in payments from pharmaceutical and medical device companies, with $478.48 received in 2024. These payments were reported across 380 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($8,323).
As a Medicare-enrolled provider, Haney has provided services to 967 Medicare beneficiaries, totaling 1,671 services with total Medicare billing of $83,609. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Ad
Practice Information
- Specialty Pediatrics
- Other Specialties Internal Medicine
- Location Louisville, KY
- Active Since 09/27/2006
- Last Updated 07/25/2017
- Taxonomy Code 208000000X
- Entity Type Individual
- NPI Number 1538250147
Products in Payments
- FARXIGA (Drug) $980.15
- APTIOM (Drug) $716.48
- Aimovig (Biological) $546.62
- ELIQUIS (Drug) $379.22
- XARELTO (Drug) $332.82
- UBRELVY (Drug) $319.08
- ENTRESTO (Drug) $299.41
- JARDIANCE (Drug) $235.51
- SYNCHROMED (Device) $218.13
- JULUCA (Drug) $203.23
- CHANTIX (Drug) $192.32
- JANUVIA (Drug) $181.07
- Proclaim IPG (Device) $180.54
- INVOKANA (Drug) $176.84
- Senza Spinal Cord Stimulation System (Device) $168.52
- UTIBRON (Drug) $167.49
- Ozempic (Drug) $151.47
- MOVANTIK (Drug) $146.13
- AIRSUPRA (Drug) $144.08
- Repatha (Biological) $139.30
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatrics Doctors in Louisville
Danny Stewart, Md, MD
Pediatrics — Payments: $482,201
Pediatrics $482,201
Dr. Gary Marshall, Md, MD
Pediatrics — Payments: $477,585
Pediatrics $477,585
Ashok Raj, Md, MD
Pediatrics — Payments: $178,221
Pediatrics $178,221
Nemr Eid, Md, MD
Pediatrics — Payments: $78,416
Pediatrics $78,416
Dr. Christian Berkhahn, Md, Ms, MD, MS
Pediatrics — Payments: $63,289
Pediatrics $63,289
Maurice Allgeier, Md, MD
Pediatrics — Payments: $34,515
Pediatrics $34,515